ARCHIVES

NCAB Can’t Decide Fate of Women’s Health Trial, Forces It Back Into Lap of DCPC Scientific Advisors

This article is from The Cancer Letter archive.

Vol. 13 No. 38 | October 2, 1987

Download PDF Visit The Full Archive

Related Articles

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987

NCCS Plans Rays Of Hope Event At Ellipse On Sept. 15.

July 27, 2001

In Brief: Organ systems Coordinating Center Decision Still Delayed; Branch Merged With DCPC Centers Branch

June 29, 1984

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Glaxo, Mass General Begin Phase III Trial Of Tykerb

December 29, 2006